Once-a-day controlled release sulfonylurea formulation

Details Once-a-day controlled release sulfonylurea formulation Once-a-day controlled release sulfonylurea formulation

2005-04-05

2005-04-05

Webman, Edward J. (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S255060, C514S866000

Reexamination Certificate

active

06875793

ABSTRACT:
This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative thereof in the matrix. Further, the use of an aqueous alkalizing medium affords substantially complete bioavailability of the drug from the matrix of the tablet. The core tablets may optionally be coated with a coating material in the range of 2% to 10% with an enteric material or with a water insoluble material like ethyl cellulose.

REFERENCES:
patent: 3485847 (1969-12-01), Bossert et al.
patent: 3784684 (1974-01-01), Bossert et al.
patent: 4191772 (1980-03-01), Woog et al.
patent: 4346709 (1982-08-01), Schmitt
patent: 4412986 (1983-11-01), Kawata et al.
patent: 4562069 (1985-12-01), Hegasy et al.
patent: 4665081 (1987-05-01), Doi et al.
patent: 4673564 (1987-06-01), Kawata et al.
patent: 4696815 (1987-09-01), Schepky et al.
patent: 4764382 (1988-08-01), Kydonieus et al.
patent: 4765989 (1988-08-01), Wong et al.
patent: 4765990 (1988-08-01), Sugimoto et al.
patent: 4792448 (1988-12-01), Ranade
patent: 4792450 (1988-12-01), Kydonieus et al.
patent: 4792452 (1988-12-01), Howard et al.
patent: 4803076 (1989-02-01), Ranade
patent: 4803081 (1989-02-01), Falk et al.
patent: 4808413 (1989-02-01), Joshi et al.
patent: 4851229 (1989-07-01), Magruder et al.
patent: 4867985 (1989-09-01), Heafield et al.
patent: 4880623 (1989-11-01), Piergiorgio et al.
patent: 4889723 (1989-12-01), Kim et al.
patent: 4892741 (1990-01-01), Ohm et al.
patent: 4894235 (1990-01-01), Kohne et al.
patent: 4904699 (1990-02-01), Bauer
patent: 4940587 (1990-07-01), Jenkins et al.
patent: 4942040 (1990-07-01), Ragnarsson et al.
patent: 4973469 (1990-11-01), Mulligan et al.
patent: 4983593 (1991-01-01), Miyajima et al.
patent: 4994276 (1991-02-01), Baichwal et al.
patent: 5007790 (1991-04-01), Shell
patent: 5015479 (1991-05-01), Mulligan et al.
patent: 5019397 (1991-05-01), Wong et al.
patent: 5024843 (1991-06-01), Kuczynski et al.
patent: 5051263 (1991-09-01), Barry et al.
patent: 5071642 (1991-12-01), Lahr et al.
patent: 5071643 (1991-12-01), Yu et al.
patent: 5091190 (1992-02-01), Kuczynski et al.
patent: 5093198 (1992-03-01), Speaker et al.
patent: 5096714 (1992-03-01), Kuhrts
patent: 5100669 (1992-03-01), Hyon et al.
patent: 5108757 (1992-04-01), Erdos et al.
patent: 5110602 (1992-05-01), Kim et al.
patent: 5128142 (1992-07-01), Mulligan et al.
patent: 5128143 (1992-07-01), Baichwal et al.
patent: 5132116 (1992-07-01), Sournac et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5135757 (1992-08-01), Baichwal et al.
patent: 5145683 (1992-09-01), Rhodes
patent: 5160734 (1992-11-01), Ganesan et al.
patent: 5169638 (1992-12-01), Dennis et al.
patent: 5169639 (1992-12-01), Baichwal et al.
patent: 5211957 (1993-05-01), Hagemann et al.
patent: 5215758 (1993-06-01), Krishnamurthy
patent: 5258185 (1993-11-01), Bauer et al.
patent: 5264446 (1993-11-01), Hegasy et al.
patent: 5264459 (1993-11-01), Chelmicka-Schorr et al.
patent: 5273760 (1993-12-01), Oshlack et al.
patent: 5286493 (1994-02-01), Oshlack et al.
patent: 5288500 (1994-02-01), Ibsen
patent: 5292534 (1994-03-01), Valentine et al.
patent: 5356467 (1994-10-01), Oshlack et al.
patent: 5415871 (1995-05-01), Pankhania et al.
patent: 5439687 (1995-08-01), Compassi
patent: 5455046 (1995-10-01), Baichwal
patent: 5472711 (1995-12-01), Baichwal
patent: 5476654 (1995-12-01), Conte et al.
patent: 5478574 (1995-12-01), Baichwal et al.
patent: 5512297 (1996-04-01), Baichwal
patent: 5518730 (1996-05-01), Fuisz
patent: 5543099 (1996-08-01), Zhang et al.
patent: 5554387 (1996-09-01), Baichwal
patent: 5629003 (1997-05-01), Horstmann et al.
patent: 5662933 (1997-09-01), Baichwal et al.
patent: 5667801 (1997-09-01), Baichwal
patent: 5670168 (1997-09-01), Baichwal et al.
patent: 5773025 (1998-06-01), Baichwal
patent: 5830497 (1998-11-01), Yamanaka et al.
patent: 5846563 (1998-12-01), Baichwal
patent: 6048548 (2000-04-01), Baichwal
patent: 6245355 (2001-06-01), Baichwal
patent: 1288049 (1991-08-01), None
patent: 2101680 (1994-02-01), None
patent: 2714065 (1978-10-01), None
patent: 3400106 (1985-07-01), None
patent: 0147171 (1985-07-01), None
patent: 0234670 (1987-02-01), None
patent: 0357793 (1990-03-01), None
patent: 460588 (1991-12-01), None
patent: 0047899 (1996-02-01), None
patent: 0232155 (1997-08-01), None
patent: 2160100 (1995-12-01), None
patent: 8504100 (1985-09-01), None
patent: WO 8902738 (1989-04-01), None
patent: WO 9206680 (1992-04-01), None
patent: 9313773 (1993-07-01), None
patent: 9423700 (1994-10-01), None
patent: 9534582 (1995-12-01), None
Chemical Abstracts, vol. 104 (1986) Abstract 174662y.
Chemical Abstracts, vol. 99 (1983) Abstract 128360d.
Chemical Abstracts, vol. 92 (1980) Abstract 135278s.
Chemical Abstracts, vol. 92 (1980) Abstract 82429h.
Chemical Abstracts, vol. 77 (1972) Abstract 39130g.
Chemical Abstracts, vol. 70 (1969) Abstract 17133p.
Chemical Abstracts, vol. 98 (1983) Abstract 221832y.
Alderman, D.A., “A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms”,Int. J. Pharm. Tech.&Prod. Mfg.,vol. 5, pp. 1-9 (1984).
Haynes, R. Brian, M.D., et al., “Manipulation of the therapeutic regimen to improve compliance: Conceptions and misconceptions”,Clinical Pharmacology and Therapeutics,vol. 22, No. 2, (Aug. 1977).
English translation of Japanese Patent Laid-Open-To-Public, publication No. 8/1986, publication date Jan. 6, 1986, Japanese Patent Application No. 118,789/1984; Japanese Patent Application date: Jun. 9, 1984.
Techniques of Solubilization of Drugs,edited by Samuel H. Yalkowsky, The Upjohn Company, pub. Marcel Dekker, Inc., New York and Basel, pp. 308-315 (1981).
“Crystalliztion and Granulation”, Remington's Practice of Pharmacy, 9th Ed. Chapter XXVII, pp. 208-211, 1950.
Ritschel, Angewandte Biopharmazie, pp. 293-302 (1973).
Sugimoto, I., et al., “Dissolution and Absorption of Nifedipine From Nifedipine-Polyvinylpyrrolidone Coprecipitate”,Drug Development and Industrial Pharmacy,vol. 6, No. 2, pp., 137-161 (1980).
Kleinblosem, M., et al., Nifedipine: Kinetics and dynamics in healthy subjects,Chin. Pharmacol. Ther.,Vo. 35, No. 6, pp. 742-749 (1984).
Ramasch, K., et al., “Pharmacokinetics and Metabolism of Nifediphine”,Hypertension Supplement II,Vo. 5, No. 4, Jul.-Aug. 18-24 (1983).
McGinty, J.W., et al., “Dissolution and Uniformity Properties of Ordered Mixes of Micronized Griseofulvin and a Directly Compressible Excipient”,Drug Development and Industrial Pharmacy,vol. 11, No. 4, pp. 891-900 (1985).
Helbig, J., et al., “Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions”,Pharmaceuticals,(Abstract-98:221837d), vol. 98, p. 63 (1983).
The Merck Index,pp. 848-849, 9th Ed. (1976).
D.Q.M. Craig, “Polyethyelene Glycols and Drug Release”,Drug Development and Industrial Pharmacy,16(17), pp. 2501-2526 (1990).
English translation of Ritschel, Angewandte Blopharmazie, pp. 293-302 (1973).
Supplementary Partial European Search Report for European Application No. 98 95 3532.

Affiliated with

Also associated with

Rating

Once-a-day controlled release sulfonylurea formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Once-a-day controlled release sulfonylurea formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Once-a-day controlled release sulfonylurea formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3416765